Memory, Executive, and Multidomain Subtle Cognitive Impairment
Jon B. Toledo,Maria Bjerke,Kewei Chen,Martin Rozycki,Clifford R. Jack,Michael W. Weiner,Steven E. Arnold,Eric M. Reiman,Christos Davatzikos,Leslie M. Shaw,John Q. Trojanowski,Michael Weiner,Paul Aisen,Ronald Petersen,William Jagust,John Q. Trojanowki,Arthur W. Toga,Laurel Beckett,Robert C. Green,Andrew J. Saykin,John Morris,Enchi Liu,Tom Montine,Anthony Gamst,Ronald G. Thomas,Michael Donohue,Sarah Walter,Devon Gessert,Tamie Sather,Danielle Harvey,John Kornak,Anders Dale,Matthew Bernstein,Joel Felmlee,Nick Fox,Paul Thompson,Norbert Schuff,Gene Alexander,Charles DeCarli,Dan Bandy,Robert A. Koeppe,Norm Foster,Chet Mathis,Nigel J. Cairns,Lisa Taylor-Reinwald,J.Q. Trojanowki,Les Shaw,Virginia M.Y. Lee,Magdalena Korecka,Karen Crawford,Scott Neu,Tatiana M. Foroud,Steven Potkin,Li Shen,Zaven Kachaturian,Richard Frank,Peter J. Snyder,Susan Molchan,Jeffrey Kaye,Joseph Quinn,Betty Lind,Sara Dolen,Lon S. Schneider,Sonia Pawluczyk,Bryan M. Spann,James Brewer,Helen Vanderswag,Judith L. Heidebrink,Joanne L. Lord,Kris Johnson,Rachelle S. Doody,Javier Villanueva-Meyer,Munir Chowdhury,Yaakov Stern,Lawrence S. Honig,Karen L. Bell,John C. Morris,Beau Ances,Sue Leon,Stacy Schneider,Daniel Marson,Randall Griffith,David Clark,Hillel Grossman,Effie Mitsis,Aliza Romirowsky,Leyla deToledo-Morrell,Raj C. Shah,Ranjan Duara,Daniel Varon,Peggy Roberts,Marilyn Albert,Chiadi Onyike,Stephanie Kielb,Henry Rusinek,Mony J de Leon,Lidia Glodzik,Susan De Santi,P. Murali Doraiswamy,Jeffrey R. Petrella,R. Edward Coleman,Jason H. Karlawish,David Wolk,Charles D. Smith,Greg Jicha,Peter Hardy,Oscar L. Lopez,MaryAnn Oakley,Donna M. Simpson,Anton P. Porsteinsson,Bonnie S. Goldstein,Kim Martin,Kelly M. Makino,M. Saleem Ismail,Connie Brand,Ruth A. Mulnard,Gaby Thai,Catherine Mc-Adams-Ortiz,Kyle Womack,Dana Mathews,Mary Quiceno,Ramon Diaz-Arrastia,Richard King,Myron Weiner,Kristen Martin-Cook,Michael DeVous,Allan I. Levey,James J. Lah,Janet S. Cellar,Jeffrey M. Burns,Heather S. Anderson,Russell H. Swerdlow,Liana Apostolova,Po H. Lu,George Bartzokis,Daniel H.S. Silverman,Neill R Graff-Radford,Francine Parfitt,Heather Johnson,Martin R. Farlow,Ann Marie Hake,Brandy R. Matthews,Scott Herring,Christopher H. van Dyck,Richard E. Carson,Martha G. MacAvoy,Howard Chertkow,Howard Bergman,Chris Hosein,Sandra Black,Bojana Stefanovic,Curtis Caldwell,Ging-Yuek Robin Hsiung,Howard Feldman,Benita Mudge,Michele Assaly,Andrew Kertesz,John Rogers,Dick Trost,Charles Bernick,Donna Munic,Diana Kerwin,Marek-Marsel Mesulam,Kristina Lipowski,Chuang-Kuo Wu,Nancy Johnson,Carl Sadowsky,Walter Martinez,Teresa Villena,Raymond Scott Turner,Kathleen Johnson,Brigid Reynolds,Reisa A. Sperling,Keith A. Johnson,Gad Marshall,Meghan Frey,Jerome Yesavage,Joy L. Taylor,Barton Lane,Allyson Rosen,Jared Tinklenberg,Marwan Sabbagh,Christine Belden,Sandra Jacobson,Neil Kowall,Ronald Killiany,Andrew E. Budson,Alexander Norbash,Patricia Lynn Johnson,Thomas O. Obisesan,Saba Wolday,Salome K. Bwayo,Alan Lerner,Leon Hudson,Paula Ogrocki,Evan Fletcher,Owen Carmichael,John Olichney,Smita Kittur,Michael Borrie,T-Y Lee,Dr Rob Bartha,Sterling Johnson,Sanjay Asthana,Cynthia M. Carlsson,Steven G. Potkin,Adrian Preda,Dana Nguyen,Pierre Tariot,Adam Fleisher,Stephanie Reeder,Vernice Bates,Horacio Capote,Michelle Rainka,Douglas W. Scharre,Maria Kataki,Earl A. Zimmerman,Dzintra Celmins,Alice D. Brown,Godfrey D. Pearlson,Karen Blank,Karen Anderson,Robert B. Santulli,Eben S. Schwartz,Kaycee M. Sink,Jeff D. Williamson,Pradeep Garg,Franklin Watkins,Brian R. Ott,Henry Querfurth,Geoffrey Tremont,Stephen Salloway,Paul Malloy,Stephen Correia,Howard J. Rosen,Bruce L. Miller,Jacobo Mintzer,Crystal Flynn Longmire,Kenneth Spicer,Elizabether Finger,Irina Rachinsky,Dick Drost,Nunzio Pomara,Raymundo Hernando,Antero Sarrael,Susan K. Schultz,Laura L. Boles Ponto,Hyungsub Shim,Karen Elizabeth Smith,Norman Relkin,Gloria Chaing,Lisa Raudin,Amanda Smith,Kristin Fargher,Balebail Ashok Raj
DOI: https://doi.org/10.1212/wnl.0000000000001738
IF: 9.9
2015-01-01
Neurology
Abstract:Objective: We studied the biomarker signatures and prognoses of 3 different subtle cognitive impairment (SCI) groups (executive, memory, and multidomain) as well as the subjective memory complaints (SMC) group. Methods: We studied 522 healthy controls in the Alzheimer9s Disease Neuroimaging Initiative (ADNI). Cutoffs for executive, memory, and multidomain SCI were defined using participants who remained cognitively normal (CN) for 7 years. CSF Alzheimer disease (AD) biomarkers, composite and region-of-interest (ROI) MRI, and fluorodeoxyglucose-PET measures were compared in these participants. Results: Using a stringent cutoff (fifth percentile), 27.6% of the ADNI participants were classified as SCI. Most single ROI or global-based measures were not sensitive to detect differences between groups. Only MRI-SPARE-AD (Spatial Pattern of Abnormalities for Recognition of Early AD), a quantitative MRI pattern-based global index, showed differences between all groups, excluding the executive SCI group. Atrophy patterns differed in memory SCI and SMC. The CN and the SMC groups presented a similar distribution of preclinical dementia stages. Fifty percent of the participants with executive, memory, and multidomain SCI progressed to mild cognitive impairment or dementia at 7, 5, and 2 years, respectively. Conclusions: Our results indicate that (1) the different SCI categories have different clinical prognoses and biomarker signatures, (2) longitudinally followed CN subjects are needed to establish clinical cutoffs, (3) subjects with SMC show a frontal pattern of brain atrophy, and (4) pattern-based analyses outperform commonly used single ROI-based neuroimaging biomarkers and are needed to detect initial stages of cognitive impairment.